companydata.dkcompanydata.dk

DIAFARM A/S: Financial statements 2022

CVR: 26638445

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

DIAFARM A/S (CVR 26638445) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 332,780 and a net result of DKK 230,683 compared with DKK 148,120 the year before. That is an increase of 21.6% compared with the year before. Equity in the 2022 report amounted to DKK 3,862,521. The solvency ratio was 76%.

Gross Profit
DKK 332,780
Profit/Loss
DKK 230,683
Equity
DKK 3,862,521
Total Assets
DKK 5,081,427

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-333K231K3.9M-
2021-274K148K3.6M0
2020-14.1M1.2M3.5M25
2019-13M1.4M3.9M19
2018-12.6M1.2M3.5M20

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on DIAFARM A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

DIAFARM A/S: The 2021 annual report is outJun 27, 2022

DIAFARM A/S has published its annual report for 2021. Gross profit came to DKK 273,730, and the net result was DKK 148,120.

About DIAFARM A/S

DIAFARM A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2002. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The company was previously named DIAFARM ApS. The management consists of Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Helene Lollike Bull and Fitzrovia ApS. The company has 29 employees (2020). In 2025, the company reported a gross profit of DKK 163,565 and a net result of DKK 137,190 compared with DKK 330,620 the year before. Equity in the 2025 report amounted to DKK 3,304,126.

Source: annual report 2025, Danish Business Authority